Elixinol Wellness Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.246x

Elixinol Wellness Ltd cash flow conversion efficiency. Based on the latest financial reports, Elixinol Wellness Ltd (EXL) has a cash flow conversion efficiency ratio of -0.246x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.83 Million ≈ $-1.30 Million USD) by net assets (AU$7.45 Million ≈ $5.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Elixinol Wellness Ltd (2002–2025)

Cash flow conversion efficiency of Elixinol Wellness Ltd from 2002 to 2025. This chart illustrates how Elixinol Wellness Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View EXL share price today for real-time trading data and today's change.

Elixinol Wellness Ltd Cash Flow Conversion Ratio Explained

Elixinol Wellness Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Elixinol Wellness Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Elixinol Wellness Ltd ranked by their cash flow conversion efficiency. Also see EXL stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
PAVmed Inc NASDAQ:PAVM	-0.035x
KATORO GOLD PLC LS-01 F:622	N/A
Spectur Ltd AU:SP3	-0.224x
Northern 3 Vct Plc LSE:NTN	-0.021x
AnalytixInsight Inc V:ALY	-0.001x
Lord Resources Ltd AU:LRD	-0.211x
Goldcliff Resource Corp V:GCN	-0.238x
CPD SA WAR:CPD	-0.023x

Annual Cash Flow Conversion Efficiency for Elixinol Wellness Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Elixinol Wellness Ltd from 2002 to 2025. Review cash generation quality of Elixinol Wellness Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$7.45 Million ≈ $5.27 Million	AU$-3.21 Million ≈ $-2.27 Million	-0.431x	-24.65%
2024-12-31	AU$10.03 Million ≈ $7.09 Million	AU$-3.47 Million ≈ $-2.45 Million	-0.346x	+18.93%
2023-12-31	AU$6.46 Million ≈ $4.57 Million	AU$-2.76 Million ≈ $-1.95 Million	-0.427x	+52.05%
2022-12-31	AU$9.16 Million ≈ $6.48 Million	AU$-8.15 Million ≈ $-5.77 Million	-0.890x	-20.68%
2021-12-31	AU$19.08 Million ≈ $13.50 Million	AU$-14.07 Million ≈ $-9.96 Million	-0.738x	-16.25%
2020-12-31	AU$35.65 Million ≈ $25.23 Million	AU$-22.62 Million ≈ $-16.01 Million	-0.635x	-38.40%
2019-12-31	AU$111.38 Million ≈ $78.81 Million	AU$-51.07 Million ≈ $-36.13 Million	-0.458x	-1154.74%
2018-12-31	AU$143.74 Million ≈ $101.70 Million	AU$-5.25 Million ≈ $-3.72 Million	-0.037x	-457.88%
2017-12-31	AU$99.09 Million ≈ $70.11 Million	AU$-649.00K ≈ $-459.21K	-0.007x	-103.27%
2005-12-31	AU$392.73 Million ≈ $277.88 Million	AU$78.77 Million ≈ $55.74 Million	0.201x	-52.91%
2004-12-31	AU$260.84 Million ≈ $184.56 Million	AU$111.09 Million ≈ $78.61 Million	0.426x	+53.92%
2003-12-31	AU$175.18 Million ≈ $123.95 Million	AU$48.47 Million ≈ $34.30 Million	0.277x	+43.04%
2002-12-31	AU$117.25 Million ≈ $82.96 Million	AU$22.68 Million ≈ $16.05 Million	0.193x	--

About Elixinol Wellness Ltd

AU:EXL Australia Drug Manufacturers - Specialty & Generic

Market Cap

$1.76 Million

AU$2.48 Million AUD

Market Cap Rank

#30172 Global

#1755 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$4.91